Organisations can uphold zero trust security benefits for noncompliant infrastructure through two methods. First, by isolating such systems within a segmented network to control access, and second, adopting a strategy employing proxy-based approach to mediate traffic and enforce policies to these parts.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
